Your browser doesn't support javascript.
loading
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
von Hoff, Katja; Haberler, Christine; Schmitt-Hoffner, Felix; Schepke, Elizabeth; de Rojas, Teresa; Jacobs, Sandra; Zapotocky, Michal; Sumerauer, David; Perek-Polnik, Marta; Dufour, Christelle; van Vuurden, Dannis; Slavc, Irene; Gojo, Johannes; Pickles, Jessica C; Gerber, Nicolas U; Massimino, Maura; Gil-da-Costa, Maria Joao; Garami, Miklos; Kumirova, Ella; Sehested, Astrid; Scheie, David; Cruz, Ofelia; Moreno, Lucas; Cho, Jaeho; Zeller, Bernward; Bovenschen, Niels; Grotzer, Michael; Alderete, Daniel; Snuderl, Matija; Zheludkova, Olga; Golanov, Andrey; Okonechnikov, Konstantin; Mynarek, Martin; Juhnke, Björn Ole; Rutkowski, Stefan; Schüller, Ulrich; Pizer, Barry; von Zezschwitz, Barbara; Kwiecien, Robert; Wechsung, Maximilian; Konietschke, Frank; Hwang, Eugene I; Sturm, Dominik; Pfister, Stefan M; von Deimling, Andreas; Rushing, Elisabeth J; Ryzhova, Marina; Hauser, Peter; Lastowska, Maria; Wesseling, Pieter.
Afiliação
  • von Hoff K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Haberler C; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Schmitt-Hoffner F; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Schepke E; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • de Rojas T; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Jacobs S; The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Zapotocky M; Pediatric OncoGenomics Unit, Children's University Hospital Niño Jesús, Madrid, Spain.
  • Sumerauer D; Department of Pediatrics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.
  • Perek-Polnik M; Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Dufour C; Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • van Vuurden D; Department of Oncology, The Children's Memorial Health Institute, University of Warsaw, Warsaw, Poland.
  • Slavc I; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France.
  • Gojo J; INSERM, Molecular Predictors and New Targets in Oncology, Paris-Saclay University, Villejuif, France.
  • Pickles JC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Gerber NU; Department of Pediatrics and Adolescent Medicine and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Massimino M; Department of Pediatrics and Adolescent Medicine and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Gil-da-Costa MJ; Developmental Biology and Cancer Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Garami M; Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Kumirova E; Department of Oncology, University Children's Hospital, Zurich, Switzerland.
  • Sehested A; Pediatric Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Scheie D; Pediatric Oncology Department, University Hospital São João, Porto, Portugal.
  • Cruz O; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Moreno L; Department of Neuro-Oncology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Cho J; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen,Denmark.
  • Zeller B; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Bovenschen N; Pediatric Oncology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Grotzer M; Paediatric Haematology and Oncology Division, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Alderete D; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Snuderl M; Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Zheludkova O; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Golanov A; Department of Oncology, University Children's Hospital, Zurich, Switzerland.
  • Okonechnikov K; Service of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina.
  • Mynarek M; Department of Pathology, NYU Langone Health and School of Medicine, New York, New York, USA.
  • Juhnke BO; Department of Neurooncology, Russian Scientific Center of Radiology, Moscow, Russia.
  • Rutkowski S; Department of Neuroradiology, Burdenko Neurosurgical Institute, Moscow, Russia.
  • Schüller U; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Pizer B; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • von Zezschwitz B; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kwiecien R; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wechsung M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Konietschke F; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hwang EI; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sturm D; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
  • Pfister SM; Institute of Translational Research, University of Liverpool, Liverpool, UK.
  • von Deimling A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Rushing EJ; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Ryzhova M; Institute of Biometry and Clinical Epidemiology, Charité University Medicine and Berlin Institute of Health, Berlin, Germany.
  • Hauser P; Institute of Biometry and Clinical Epidemiology, Charité University Medicine and Berlin Institute of Health, Berlin, Germany.
  • Lastowska M; Department of Pediatric Hematology-Oncology, Center for Cancer and Immunology Research and Neuroscience Research, Children's National Medical Center, Washington DC, USA.
  • Wesseling P; Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Neuro Oncol ; 23(9): 1597-1611, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34077956

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias do Sistema Nervoso Central / Tumores Neuroectodérmicos Primitivos / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias do Sistema Nervoso Central / Tumores Neuroectodérmicos Primitivos / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha